Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax
Antimicrobial Agents and Chemotherapy · 02.05.2024 · 68 (5)
DOI: 10.1128/aac.00280-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 02.05.2024. Verfasst von Peter Christensen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Doxycycline, Antimalarials, Aminoquinolines, Plasmodium vivax. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Manatu Hauora | Health Research Council of New Zealand (HRC), Agence Nationale de la Recherche (ANR), Agency for Science, Technology and Research (A*STAR).
Abstract (Originalsprache)
Testing Plasmodium vivax antimicrobial sensitivity is limited to ex vivo schizont maturation assays, which preclude determining the IC50s of delayed action antimalarials such as doxycycline. Using Plasmodium cynomolgi as a model for P. vivax , we determined the physiologically significant delayed death effect induced by doxycycline [IC 50(96 h) , 1,401 ± 607 nM]. As expected, IC 50(96 h) to chloroquine (20.4 nM), piperaquine (12.6 µM), and tafenoquine (1,424 nM) were not affected by extended exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
- Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.
- A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), , Singapore.
- Department of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Sakamoto, Nagasaki, Japan.
- Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
ORCID-Profile: Dennis E Kyle, Htin Lin Aung, Gregory M Cook, Bruce Russell
Förderung
- Manatu Hauora | Health Research Council of New Zealand (HRC)
- Agence Nationale de la Recherche (ANR)
- Agency for Science, Technology and Research (A*STAR)
Zitieren
APA
Christensen, P., Cinzah, R., Suwanarusk, R., Chua, A. C. Y., Kaneko, O., Kyle, D. E., Aung, H. L., Matheson, J., Bifani, P., Rénia, L., Cook, G. M., Snounou, G., & Russell, B. (2024). Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax. Antimicrobial Agents and Chemotherapy, 68(5). https://doi.org/10.1128/aac.00280-24
Vancouver
Christensen P, Cinzah R, Suwanarusk R, Chua ACY, Kaneko O, Kyle DE, et al. Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax. Antimicrobial Agents and Chemotherapy. 2024;68(5). doi:10.1128/aac.00280-24
BibTeX
@article{Christensen2024,
author = {Christensen, Peter and Cinzah, Rosy and Suwanarusk, Rossarin and Chua, Adeline Chiew Yen and Kaneko, Osamu and Kyle, Dennis E and Aung, Htin Lin and Matheson, Jessica and Bifani, Pablo and Rénia, Laurent and Cook, Gregory M and Snounou, Georges and Russell, Bruce},
title = {Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
volume = {68},
number = {5},
doi = {10.1128/aac.00280-24}
}
EUVIMED